Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

The Hill

FDA moves to fast-track review of 3 psychedelic drug studies

FDA moves to fast-track review of 3 psychedelic drug studies
ShareXFacebook

The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression and post-traumatic stress disorder (PTSD), the latest step by the Trump administration toward possible approval. The agency did not disclose the specific companies that were granted priority review vouchers. Two companies are studying psilocybin; one for

T

Source

The Hill

Read full article at The Hill

Opens original article in a new tab

Advertisement

Related Politics Stories

DOJ dropping its probe in Fed Chair Powell is ‘predictable’: Former Trump WH attorney
NBC Politics

DOJ dropping its probe in Fed Chair Powell is ‘predictable’: Former Trump WH attorney

NBC News correspondent Tom Winter reports on the indictment of a U.S. special forces soldier who allegedly used classified information to bet on the raid that captured Nicolas Maduro. Former Trump White House attorney Ty Cobb joins Meet the Press NOW to weigh in on the political and national security implications of prediction markets. Cobb also reacts to the DOJ dropping its investigation to Federal Reserve Chair Jerome Powell and whether he thinks the president will abide by the War Power Act

Read more →
Newsom dodges endorsement but muddles overall message
Washington Examiner

Newsom dodges endorsement but muddles overall message

California Gov. Gavin Newsom (D-CA) is once again trying to thread a political needle, only this time, he may be tying himself in knots. Asked directly this week whether he would back a candidate in the state’s gubernatorial race, the outgoing governor, who is widely expected to run for president in 2028, sidestepped with a […]

Read more →
Advertisement